2007
DOI: 10.1590/s1413-86702007000200029
|View full text |Cite
|
Sign up to set email alerts
|

Vibrio vulnificus infection in São Paulo, Brazil: case report and literature review

Abstract: Non cholera Vibrio may cause conjunctivitis, wound infection, gastroenteritis and serious sepsis. Transmission to men is through contact with skin, mucosa or wounds exposed to marine water, and consumption of certain barely cooked or raw seafood, more frequently in the summer. This is one of the first cases of severe infection related to Vibrio vulnificus described in Brazil. The patient was an old man, who ingested seafood in Guarujá, a seashore city near São Paulo, 3 days before hospitalization. He was admit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 14 publications
0
8
0
Order By: Relevance
“…Among the classes of antimicrobial drugs reliably active against the organism are third-generation cephalosporins (cefotaxime, ceftriaxone, or ceftazidime), betalactam-beta-lactamase inhibitors (piperacillin-tazobactam), carbapenems (imipenem-cilastatin), tetracyclines (minocycline or doxycycline), aminoglycosides (gentamicin or amikacin), fluoroquinolones (ciprofloxacin, moxifloxacin, or levofloxacin), and miscellaneous agents such as trimethoprim-sulfamethoxazole or chloramphenicol. [75][76][77][78][79][80][81] The CDC recommends treatment of wound infections in adults with ceftazidime 1 to 2 g IV/intramuscular (IM) every 8 h in combination with doxycycline 100 mg IV/peroral (PO) twice daily (7 to 14 days). The literature consensus for primary sepsis is similar, with ceftazidime 2 g IV every 8 h in combination again with doxycycline 100 mg IV/PO every 12 h. Combination antimicrobial therapy appears to be the preferred regimen for serious infection, although some animal studies suggest monotherapy (e.g., fluoroquinolone) may be just as effective.…”
Section: Treatmentmentioning
confidence: 99%
“…Among the classes of antimicrobial drugs reliably active against the organism are third-generation cephalosporins (cefotaxime, ceftriaxone, or ceftazidime), betalactam-beta-lactamase inhibitors (piperacillin-tazobactam), carbapenems (imipenem-cilastatin), tetracyclines (minocycline or doxycycline), aminoglycosides (gentamicin or amikacin), fluoroquinolones (ciprofloxacin, moxifloxacin, or levofloxacin), and miscellaneous agents such as trimethoprim-sulfamethoxazole or chloramphenicol. [75][76][77][78][79][80][81] The CDC recommends treatment of wound infections in adults with ceftazidime 1 to 2 g IV/intramuscular (IM) every 8 h in combination with doxycycline 100 mg IV/peroral (PO) twice daily (7 to 14 days). The literature consensus for primary sepsis is similar, with ceftazidime 2 g IV every 8 h in combination again with doxycycline 100 mg IV/PO every 12 h. Combination antimicrobial therapy appears to be the preferred regimen for serious infection, although some animal studies suggest monotherapy (e.g., fluoroquinolone) may be just as effective.…”
Section: Treatmentmentioning
confidence: 99%
“…The patient died after 12 days, due to fungaemia caused by Candida albicans (Araujo et al . ). The third case in Brazil occurred in Paraná State, in 2013.…”
Section: Vibrio Vulnificus Occurrence In South Americamentioning
confidence: 97%
“…The risk of V. vulnificus infection is higher in individuals with a compromised immune system, such as people with chronic liver disease, alcoholism, diabetes, and hemochromatosis (Bross et al, 2007;Barton and Acton, 2009;Yun and Kim, 2018). The Centers for Disease Control and Prevention of the United States (CDC) estimates that around 80,000 people get vibrio infections every year, including 500 hospitalizations and 100 deaths, with V. vulnificus as the most prevalent causal agent (Araujo et al, 2007;Scallan et al, 2011;Oliver, 2015;CDC, 2018).…”
Section: Introductionmentioning
confidence: 99%